18301 Von Karman Avenue Suite 130, Irvine, California, 92612, United States
Develops curative and regenerative medicines using stem cell technology.
Total Raised
$44 M
Rounds
4
Links
Verticals
Series B
Feb 2020
$25M
Equity
Jul 2018
$2M
Jun 2018
$15M
Series A
Jun 2016
Hans Keirstead
CEO
Hans S. Keirstead
Chairman and Chief Executive Officer
Scott Burell
Chief Financial Officer
James Langford
Vice President Clinical Operations
